The company now expects adjusted earnings before interest, taxes, depreciation, and amortization to range from $425 million to $435 million.
The revised full-year estimates were prompted because a "soft" cold and flu season hurt fourth-quarter results, President and Chief Executive Heyward Donigan said in a statement.
Other factors included COVID-19 prompting customers to defer elective procedures, hurting prescriptions for acute care. And inclement weather hurt Rite Aid's supply chain and company sales.
Recap TheStreet Live: Everything Jim Cramer Is Watching Thursday